These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 21039786)
1. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema. Göksel O; Aydin O; Misirligil Z; Demirel YS; Bavbek S J Dermatol; 2010 Nov; 37(11):973-9. PubMed ID: 21039786 [TBL] [Abstract][Full Text] [Related]
2. Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide. Inomata N; Osuna H; Yamaguchi J; Onoda M; Takeshita Y; Chiba Y; Kambara T; Ikezawa Z J Dermatol; 2007 Mar; 34(3):172-7. PubMed ID: 17291297 [TBL] [Abstract][Full Text] [Related]
3. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib. Bavbek S; Celik G; Ozer F; Mungan D; Misirligil Z J Asthma; 2004 Feb; 41(1):67-75. PubMed ID: 15046380 [TBL] [Abstract][Full Text] [Related]
4. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003 [TBL] [Abstract][Full Text] [Related]
5. Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs. Senna GE; Passalacqua G; Dama A; Crivellaro M; Schiappoli M; Bonadonna P; Canonica GW Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):393-6. PubMed ID: 14768525 [TBL] [Abstract][Full Text] [Related]
6. Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study. Bavbek S; Dursun AB; Dursun E; Eryilmaz A; Misirligil Z Int Arch Allergy Immunol; 2007; 142(1):64-9. PubMed ID: 17016059 [TBL] [Abstract][Full Text] [Related]
7. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs. Doña I; Blanca-López N; Jagemann LR; Torres MJ; Rondón C; Campo P; Gómez AI; Fernández J; Laguna JJ; Rosado A; Blanca M; Canto G Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936 [TBL] [Abstract][Full Text] [Related]
9. Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs. Quaratino D; Romano A; Di Fonso M; Papa G; Perrone MR; D'Ambrosio FP; Venuti A Ann Allergy Asthma Immunol; 2000 Jun; 84(6):613-7. PubMed ID: 10875490 [TBL] [Abstract][Full Text] [Related]
10. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance. Bavbek S; Celik G; Ediger D; Mungan D; Demirel YS; Misirligil Z J Asthma; 1999 Dec; 36(8):657-63. PubMed ID: 10609620 [TBL] [Abstract][Full Text] [Related]
11. Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity? Çelik GE; Erkekol FÖ; Aydın Ö; Demirel YS; Mısırlıgil Z Allergol Immunopathol (Madr); 2013; 41(3):181-8. PubMed ID: 23031659 [TBL] [Abstract][Full Text] [Related]
12. Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance. Prieto A; De Barrio M; Martín E; Fernández-Bohórquez M; de Castro FJ; Ruiz FJ; Herrero T; Tornero P; Rubio M J Allergy Clin Immunol; 2007 Apr; 119(4):960-4. PubMed ID: 17292954 [TBL] [Abstract][Full Text] [Related]
13. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs. Corzo JL; Zambonino MA; Muñoz C; Mayorga C; Requena G; Urda A; Gallego C; Blanca M; Torres MJ Br J Dermatol; 2014 Mar; 170(3):725-9. PubMed ID: 24116718 [TBL] [Abstract][Full Text] [Related]
14. [Urticaria--angioedema induced by non-steroidal anti-inflammatory analgesics]. Díez Gómez ML; Alvarez Cuesta E; Hinojosa Macías M; García Cañadillas F; Alcover Sánchez R Allergol Immunopathol (Madr); 1984; 12(3):179-88. PubMed ID: 6332509 [TBL] [Abstract][Full Text] [Related]
15. Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema. Nosbaum A; Braire-Bourrel M; Dubost R; Faudel A; Parat S; Nicolas JF; Bérard F Ann Allergy Asthma Immunol; 2013 Apr; 110(4):263-6. PubMed ID: 23535090 [TBL] [Abstract][Full Text] [Related]
16. Rofecoxib, as a safe alternative for acetyl salicylic acid/nonsteroidal anti-inflammatory drug-intolerant patients. Bavbek S; Celik G; Pasaoglu G; Misirligil Z J Investig Allergol Clin Immunol; 2006; 16(1):57-62. PubMed ID: 16599250 [TBL] [Abstract][Full Text] [Related]
17. Provocation tests with the offending nonsteroidal anti-inflammatory drugs in patients with urticaria/angioedema reactions. Zisa G; Riccobono F; Bommarito L; D'Antonio C; Calamari AM; Poppa M; Moschella MA; Di Pietrantonj C; Galimberti M Allergy Asthma Proc; 2012; 33(5):421-6. PubMed ID: 23026184 [TBL] [Abstract][Full Text] [Related]
18. Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs. Asero R Clin Exp Allergy; 2005 Jun; 35(6):713-6. PubMed ID: 15969659 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders. Asero R Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483 [TBL] [Abstract][Full Text] [Related]
20. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions. Quiralte J; Blanco C; Delgado J; Ortega N; Alcntára M; Castillo R; Anguita JL; Sáenz de San Pedro B; Carrillo T J Investig Allergol Clin Immunol; 2007; 17(3):182-8. PubMed ID: 17583106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]